SCHEMBL10463522

SCHEMBL10463522

CCOC(=O)CCCc1ccc(CCN)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.59
CYP4F2 P78329 2/20 0.58
CYP4A11 Q02928 2/20 0.58
CYP4Z1 Q86W10 3/20 0.58
CYP4F11 Q9HBI6 1/20 0.58
CYP4F12 Q9HCS2 1/20 0.58
ALOX5 P09917 1/20 0.56
MAPK1 P28482 2/20 0.55
GAA P10253 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HTR2A P28223 1/20 0.49
FAAH O00519 1/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TAAR1 Q96RJ0 2/20 0.46
CYP2A6 P11509 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11489404 0.98 CYP1A2 (0.58) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
SCHEMBL9331606 0.95 CYP4Z1 (0.59) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
Hydrochloric Acid SCHEMBL9265306 0.94 CYP4Z1 (0.58) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
SCHEMBL10463270 0.93 CYP1A2 (0.65) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
Hydrochloric Acid SCHEMBL11473826 0.92 CYP4Z1 (0.56) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
Hydrochloric Acid SCHEMBL11481637 0.92 CYP4Z1 (0.56) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
Hydrochloric Acid SCHEMBL11472241 0.92 CYP4Z1 (0.56) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
SCHEMBL1467579 0.90 CYP4F2 (0.58) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
SCHEMBL8819359 0.90 CYP4F2 (0.72) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11
Hydrochloric Acid SCHEMBL11479609 0.89 CYP4Z1 (0.57) CYP1A2CYP4F2CYP4A11CYP4Z1CYP4F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4948809-A TREATMENT OF AILMENTS DUE TO THROMBOCYTE AGGREGATION OR KIDNEY DYSFUNCTION BOEHRINGER MANNHEIM GMBH (DE) 1990-08-14 US disclosed